outcomes research

Research in Review

HER2 Inhibitors Demonstrate Variable Effects in Solid Cancers

07/25/2017

JCP Editors

Human epidermal growth factor receptor 2 (HER2)-targeted therapy results in different objective response rates (ORR) across cancer types based on mutation variants, according to recent research. ----- Related...

Human...

07/25/2017

Journal of Clinical Pathways

Research in Review

Immunotherapy Diminishes Regulatory T-Cells, Improves Outcomes in AML

07/20/2017

JCP Editors

Immunotherapy after complete remission in acute myeloid leukemia (AML) is associated with decreasing levels of regulatory T-cells, which leads to favorable clinical outcomes, according to research published in Cancer...

...

07/20/2017

Journal of Clinical Pathways

Research in Review

Is Active Surveillance Beneficial for Patients With Intermediate-Risk Prostate Cancer?

07/20/2017

JCP Editors

Recent research explored the potential of a subset of patients with intermediate-risk prostate cancer likely to benefit from active surveillance. Active surveillance is currently recommended for patients with...

Recent...

07/20/2017

Journal of Clinical Pathways

Research in Review

SBRT Deemed Safe and Effective in Older Patients With Lung Cancer

07/19/2017

JCP Editors

Stereotactic body radiation therapy (SBRT) is a safe treatment for patients aged 80 years or older with early-stage lung cancer, according to a recent study published in the International Journal of Radiation...

...

07/19/2017

Journal of Clinical Pathways

Research in Review

Predictor of Aggressive Disease in Multiple Myeloma Identified

07/18/2017

JCP Editors

Certain patients with multiple myeloma often have poorer outcomes, according to a recent meta-analysis. ----- Related Content Circulating tumor cells may help guide bladder cancer treatment Plasma ghrelin levels...

...

07/18/2017

Journal of Clinical Pathways

Research in Review

Triplet Combination Shows Durable Responses in Advanced Multiple Myeloma

07/17/2017

JCP Editors

Patients with heavily treated multiple myeloma showed rapid and durable responses to a novel treatment combination, according to a recent study published in Blood (July 2017;...

...

07/17/2017

Journal of Clinical Pathways

Research in Review

Prognostic Indicator Identified for Patients With DLBCL

07/14/2017

JCP Editors

Patients with diffuse large B-cell lymphoma (DLBCL) with a specific disease characteristic are expected to have poor clinical outcomes, according to research published in Leukemia (published online July 12, 2017;...

...

07/14/2017

Journal of Clinical Pathways

Research in Review

Altered B-Cell Composition May Impact Immunotherapy Effectiveness in AML

07/13/2017

JCP Editors

Initial chemotherapy often alters B-cell composition and immunity in patients with acute myeloid leukemia (AML), which may have implications for the success of further immunotherapy, according to research published...

...

07/13/2017

Journal of Clinical Pathways

Research in Review

Mastectomy Not Cost-Effective for Most Patients With Ovarian Cancer

07/12/2017

JCP Editors

Risk-reducing mastectomy within five years of ovarian cancer diagnosis is not cost-effective compared with surveillance for patients with BRCA mutations, according to research published in Annals of Surgical Oncology...

...

07/12/2017

Journal of Clinical Pathways

Research in Review

Blood Test Predicts Survival Outcomes in Patients With Type of Lung Cancer

07/11/2017

JCP Editors

A blood-based proteomic test offers prognostic information and optimal second-line treatment guidance for patients with squamous cell carcinoma (SCC) of the lung, according to research published in Lung Cancer (July...

A...

07/11/2017

Journal of Clinical Pathways